Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study (NCT05797896)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (22 Sites)

• Global Research Management — Glendale, California
• Northern California Retina Vitreous Associates — Mountain View, California
• Midwest Eye Institute — Carmel, Indiana
• Mid Atlantic Retina Specialists — Hagerstown, Maryland
• Sierra Eye Associates — Reno, Nevada
• Verum Research LLC — Eugene, Oregon
• Mid Atlantic Retina — Philadelphia, Pennsylvania
• Retina Research Institute of Texas — Abilene, Texas
• Texas Retina Associates — Plano, Texas
• San Antonio Eye Center — San Antonio, Texas
• Belfast City Hospital — Belfast,
• Bradford Royal Infirmary — Bradford,
• Frimley Park Hospital — Frimley,
• Gloucestershire Royal Hospital — Gloucester,
• Liverpool Hospital — Liverpool,
• Moorfields Eye Hospital — London,
• Western Eye Hospital — London,
• Manchester Royal Eye Hospital — Manchester,
• Newcastle Hospital — Newcastle,
• Nottingham City Hospital — Nottingham,
• University Hospital Southampton — Southampton,
• Sunderland Eye Infirmary — Sunderland,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Dry Age-related Macular Degeneration

• Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III) — Beverly Hills, California
• Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) — Beverly Hills, California
• Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD — Phoenix, Arizona
• A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) — Beverly Hills, California
• Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration — Baltimore, Maryland

Explore by condition: All Dry Age-related Macular Degeneration clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.